DISTRIBUTION AGREEMENTDistribution Agreement • February 3rd, 2021 • Replicel Life Sciences Inc. • Biological products, (no disgnostic substances) • British Columbia
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionREPLICEL LIFE SCIENCES INC., a corporation existing under the laws of British Columbia, having offices at 900 - 570 Granville Street, Vancouver, British Columbia, Canada V6C 3P1
ROYALTY PARTICIPATION AGREEMENTRoyalty Participation Agreement • February 3rd, 2021 • Replicel Life Sciences Inc. • Biological products, (no disgnostic substances) • British Columbia
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionTHIS ROYALTY PARTICIPATION AGREEMENT (this "Agreement"), made and entered into as of January 22, 2021 (the "Effective Date"), by and between:
SHARE PURCHASE AGREEMENTShare Purchase Agreement • February 3rd, 2021 • Replicel Life Sciences Inc. • Biological products, (no disgnostic substances) • British Columbia
Contract Type FiledFebruary 3rd, 2021 Company Industry JurisdictionShare Purchase Agreement dated January 22, 2020 among RepliCel Life Sciences Inc. (the "Corporation") and MainPointe Pharmaceuticals, LLC (the "Purchaser").